期刊文献+

癌基因RhoA对乳腺癌细胞血管内皮生长因子表达的调控机制研究 被引量:3

Regulatory mechanism of oncogene Rho A on the expression of vascular epithelial growth factor in breast cancer cells
原文传递
导出
摘要 目的探讨乳腺癌细胞MDA-MB-231中癌基因Rho A对VEGF蛋白表达和胞外分泌的影响及可能的分子机制。方法将Rho A过表达质粒pc DNA3.0-V14Rho A、对照质粒pc DNA3.0、Rho A沉默质粒pc DNA3.0-shRho A转染到MDA-MB-231细胞中,通过Western blot和ELISA实验分别检测细胞内外VEGF蛋白的表达,通过Western blot和实时PCR方法分别检测Rho A对p53表达的影响及对VEGF的调控作用。均数比较用t检验;计量资料用x珋±s表示,采用方差分析。结果 MDA-MB-231细胞中上调Rho A表达后,胞内VEGF的蛋白表达水平增加;胞外分泌水平显著增加,与对照组相比差异具有统计学意义(F=4.020,P=0.032);MDA-MB-231细胞中沉默Rho A表达后,胞内VEGF的蛋白表达水平降低;胞外分泌水平显著降低,与对照组相比差异具有统计学意义(F=5.131,P=0.001);并且与0 h相比,在MDA-MB-231细胞中上调Rho A可以抑制p53的表达(48 h:F=3.231,P=0.043),而p53表达的降低可以增加VEGF的表达水平(48 h:F=3.226,P=0.015),均差异具有统计学意义。结论乳腺癌细胞MDA-MB-231中Rho A表达的变化可以引起胞内外VEGF水平的变化,并且Rho A可能是通过抑制p53的表达从而增加VEGF表达。 Objective To explore the effects of oncogene RhoA on protein expression of vascular epithelial growth factor(VEGF) and exocytosis in breast cancer cell line MDA-MB-231 and its potential molecular mechanism. Methods RhoA-overexpressed plasmid pcDNA3.0-V14RhoA, control plasmid peDNA3.0 and RhoA-silencing plasmid pcDNA3.0-shRhoA were transfected into MDA-MB-231 cells. After that, VEGF protein expression was detected by Western blot and ELISA assay. The effects of RhoA on p53 expression and on VEGF regulation were examined by Western blot or real-time PCR. The means were compared using t text, and the measurement data were expressed as x^- ± s and processed using analysis of variance. Results After up-regulating RhoA in MDA-MB-231 cells, intracellular VEGF protein level and extracellular secretion level were significantly increased compared with the control group (F = 4. 020, P = 0.032), while after down-regulating RhoA in MDA-MB-231 cells, intracellular VEGF protein level and extracellular secretion level were significantly decreased compared with the control group (F=5. 131, P = 0. 001 ). Compared with the control group, the upregulation of RhoA could inhibit p53 expression ( 48 h : F = 3. 231 ,P=0. 043)and the decrease of p53 expression could promote VEGF expression(48 h:F=3. 226,P= 0. 015). Conclusion In breast cancer MDA-MB-231 cells, the change of RhoA expression can cause the change of intracellular and extracellular VEGF expression, and RhoA may promote VEGF expression through inhibiting p53 expression.
作者 赵庆丽 马骥
出处 《中华乳腺病杂志(电子版)》 CAS 2014年第5期16-18,共3页 Chinese Journal of Breast Disease(Electronic Edition)
基金 国家自然科学基金资助项目(81202085)
关键词 乳腺肿瘤 血管内皮生长因子类 RHOA P53 Breast neoplasms Vascular endothelial growth factors RhoA p53
  • 相关文献

参考文献12

  • 1Wang Y, Zheng XR, Riddick N, et al. ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells[J]. Circ Res,2009,104(4) :531-540.
  • 2Aspenstrfim P, Ruusala A, Pacholsky D. Taking Rho GTPases to the next level : the cellular functions of atypical Rho GTPases [ J ]. Exp Cell Res, 2007,313 ( 17 ) :3673-3679.
  • 3Wu M, Wu ZF, Rosenthal DT, et al. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers [J]. Cancer, 2010,116(11 Suppl) :2768-2782.
  • 4Chang CC, Tsai SY, Lin H, et al. Aryl-hydrocarbon receptor- dependent alteration of FAK/RhoA in the inhibition of HUVEC motility by 3-methylcholanthrene[ J]. Cell Mol Life Sci ,2009, 66(19) :3193-3205.
  • 5Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch [ J ]. Nat Rev Cancer, 2003,3 ( 6 ) :401-410.
  • 6Ferrara N. Vascular endothelial growth factor[ J ]. Arterioseler Thromb Vase Biol,2009,29(6) :789-791.
  • 7Ogata S, Morishige K, Sawada K, et al. Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells[J]. Int J Gyneeol Cancer, 2009,19(9) :1473-1480.
  • 8Li H, Peng W, Jian W, et al. ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-I expression and monoeyte-endothelial cell adhesion [ J ]. Cardiovase Diabeto1,2012, 1 1:65.
  • 9Quartuccio SM, Lantvit DD, Bosland MC, et al. Conditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative epithehum-hned inclusion cysts or teratomas [ J J. PLoS One, 2013,8 ( 5 ) : e65067EGF) expression in mammary carcinoma [ J ]. Cancer Res,2001,61 (18) :6952-6957.
  • 10Zietz C, Rosse M, Haas C, et aL MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas [ J ]. Am J Pathol, 1998,153 (5) : 1425-1433.

二级参考文献12

  • 1Wang Y, Zheng XR, Riddick N, et al. ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells[J]. Circ Res,2009,104(4) :531-540.
  • 2Aspenstrfim P, Ruusala A, Pacholsky D. Taking Rho GTPases to the next level : the cellular functions of atypical Rho GTPases [ J ]. Exp Cell Res, 2007,313 ( 17 ) :3673-3679.
  • 3Wu M, Wu ZF, Rosenthal DT, et al. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers [J]. Cancer, 2010,116(11 Suppl) :2768-2782.
  • 4Chang CC, Tsai SY, Lin H, et al. Aryl-hydrocarbon receptor- dependent alteration of FAK/RhoA in the inhibition of HUVEC motility by 3-methylcholanthrene[ J]. Cell Mol Life Sci ,2009, 66(19) :3193-3205.
  • 5Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch [ J ]. Nat Rev Cancer, 2003,3 ( 6 ) :401-410.
  • 6Ferrara N. Vascular endothelial growth factor[ J ]. Arterioseler Thromb Vase Biol,2009,29(6) :789-791.
  • 7Ogata S, Morishige K, Sawada K, et al. Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells[J]. Int J Gyneeol Cancer, 2009,19(9) :1473-1480.
  • 8Li H, Peng W, Jian W, et al. ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-I expression and monoeyte-endothelial cell adhesion [ J ]. Cardiovase Diabeto1,2012, 1 1:65.
  • 9Quartuccio SM, Lantvit DD, Bosland MC, et al. Conditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative epithehum-hned inclusion cysts or teratomas [ J J. PLoS One, 2013,8 ( 5 ) : e65067EGF) expression in mammary carcinoma [ J ]. Cancer Res,2001,61 (18) :6952-6957.
  • 10Zietz C, Rosse M, Haas C, et aL MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas [ J ]. Am J Pathol, 1998,153 (5) : 1425-1433.

共引文献2

同被引文献22

  • 1Wang Y, Zheng XR, Riddick N, et al. ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells[J]. Circ Res,2009,104(4) :531-540.
  • 2Aspenstrfim P, Ruusala A, Pacholsky D. Taking Rho GTPases to the next level : the cellular functions of atypical Rho GTPases [ J ]. Exp Cell Res, 2007,313 ( 17 ) :3673-3679.
  • 3Wu M, Wu ZF, Rosenthal DT, et al. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers [J]. Cancer, 2010,116(11 Suppl) :2768-2782.
  • 4Chang CC, Tsai SY, Lin H, et al. Aryl-hydrocarbon receptor- dependent alteration of FAK/RhoA in the inhibition of HUVEC motility by 3-methylcholanthrene[ J]. Cell Mol Life Sci ,2009, 66(19) :3193-3205.
  • 5Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch [ J ]. Nat Rev Cancer, 2003,3 ( 6 ) :401-410.
  • 6Ferrara N. Vascular endothelial growth factor[ J ]. Arterioseler Thromb Vase Biol,2009,29(6) :789-791.
  • 7Ogata S, Morishige K, Sawada K, et al. Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells[J]. Int J Gyneeol Cancer, 2009,19(9) :1473-1480.
  • 8Li H, Peng W, Jian W, et al. ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-I expression and monoeyte-endothelial cell adhesion [ J ]. Cardiovase Diabeto1,2012, 1 1:65.
  • 9Quartuccio SM, Lantvit DD, Bosland MC, et al. Conditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative epithehum-hned inclusion cysts or teratomas [ J J. PLoS One, 2013,8 ( 5 ) : e65067EGF) expression in mammary carcinoma [ J ]. Cancer Res,2001,61 (18) :6952-6957.
  • 10Zietz C, Rosse M, Haas C, et aL MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas [ J ]. Am J Pathol, 1998,153 (5) : 1425-1433.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部